+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Hartford Multifactor Developed Markets (ex-US) ETF

RODMARCA

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$29.52

0.080.26%

At close: -

News

Holdings Dividends Short Interest

Latest news for Hartford Multifactor Developed Markets (ex-US) ETF (ARCA:RODM)

Hartford Multifactor Developed Markets (ex-US) ETF (ARCA: RODM)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, March 13, 2018

Hartford Lowers Fees On 6 Smart Beta ETFs
Benzinga

Thursday, December 15, 2016

More ETF Fee Cuts, This Time From Hartford
Benzinga

Tuesday, May 15, 2012

Rodman & Renshaw Announces New Chairman; Exploring Alternatives for Investment Banking
Benzinga

Monday, March 12, 2012

Rodman & Renshaw Capital Group Regains NASDAQ Compliance
Benzinga

Monday, February 13, 2012

Rodman & Renshaw Acquires Assets of the Investor Relations Group
Benzinga

Tuesday, November 01, 2011

Rodman Announces Private Placement Financing of Convertible Debt and Warrants
Benzinga

Friday, August 12, 2011

Earnings Scheduled For August 12
Benzinga

Monday, July 18, 2011

Rodman & Renshaw, LLC Announces Exercise of Over-Allotment Option of Underwritten Offering of Common Stock by Towerstream Corporation
Benzinga

Monday, July 11, 2011

Michael G. King, Jr., Re-Joins Rodman & Renshaw as Managing Director
Benzinga

Thursday, June 09, 2011

GeoGlobal Announces Review of Strategic Alternatives
Benzinga

Thursday, May 19, 2011

NetSol Technologies Signs MOU With Brasilinvest Group to Launch Joint Venture in Brazil
Benzinga

Sunday, May 08, 2011

Top Investment Services stocks Buy Signals- SMHG, LTS, ENV, RODM, MSCI, ICH, LAB, COWN, FXCM, ICE, CRT, VRTS…
Benzinga

Tuesday, March 29, 2011

BATS Global Markets To Launch Prinary Listings Market In U.S. In Q4 (NYX, NDAQ, RODM)
Benzinga
BATS Global Markets To Launch Prinary Listings Market In U.S. In Q4 (NYX, NDAQ, RODM)
Benzinga

Friday, March 25, 2011

Rodman & Renshaw Acts as a Co-Manager to Prime Acquisition Initial Public Offering
Benzinga
Rodman & Renshaw Acts as a Co-Manager to Prime Acquisition Initial Public Offering
Benzinga
Hyperdynamics Prices Public Offering of Common Stock
Benzinga

Wednesday, February 16, 2011

Rodman Reports Q4 EPS of $0.05 vs. $0.05
Benzinga

Wednesday, January 26, 2011

Rodman & Renshaw Acts as Exclusive Placement Agent and Advisor in 22nd Century Group, Inc. Merger and $5.4 Million Private Placement Offering
Benzinga

Thursday, January 13, 2011

Rodman & Renshaw Acts as a Co-Manager to GeoResources Inc. on Offering
Benzinga

Monday, January 03, 2011

Biotech/Pharma Stock News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Closes $18 Million Registered Direct Offering to Fund LibiGel for Female Sexual Dysfunction
Benzinga

Tuesday, December 28, 2010

Rodman & Renshaw Acts as Exclusive Placement Agent to BioSante Pharmaceuticals,on $18.0 Million RDO
Benzinga

Wednesday, December 22, 2010

Rodman & Renshaw Acts as Exclusive Placement Agent to CAMAC Energy Inc. on $20.0 Million RDO
Benzinga
Dealmaker's Long Trip Through China RTO
Benzinga

Monday, November 15, 2010

Rodman Announces $5M Share Buyback
Benzinga
Rodman Reports Third Quarter EPS of $(0.10)
Benzinga

Tuesday, September 14, 2010

Rodman and FINRA Reach Preliminary Agreement on Terms for Rodman Acquisition
Benzinga

Wednesday, August 18, 2010

Rodman & Renshaw Could Benefit From Increased M&A (RODM)
Benzinga

Monday, July 19, 2010

Rodman & Renshaw Announces Analyst Discussion with Cleveland BioLabs, Inc. (RODM)
Benzinga

Thursday, May 27, 2010

Mid-Day Market Movers (FSII, SAPX, PERF, RODM)
Benzinga

Thursday, May 06, 2010

Market Update: RODM, HIL, PPC All Washed Out!!
Benzinga

Tuesday, October 27, 2009

BioMarin (BMRN) Acquires Aceras BioMedical Portfolio Company
Benzinga

Wednesday, October 21, 2009

Rodman & Renshaw (RODM) Shares Down: Files $75 Million Mixed Securities Shelf
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved